Search Results - "Papademetriou, Vasilios"

Refine Results
  1. 1
  2. 2
  3. 3

    Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial by Worthley, Stephen G, Tsioufis, Costas P, Worthley, Matthew I, Sinhal, Ajay, Chew, Derek P, Meredith, Ian T, Malaiapan, Yuvi, Papademetriou, Vasilios

    Published in European heart journal (21-07-2013)
    “…Catheter-based renal artery sympathetic denervation has emerged as a novel therapy for treatment of patients with drug-resistant hypertension. Initial studies…”
    Get full text
    Journal Article
  4. 4

    Orthostatic hypotension: From pathophysiology to clinical applications and therapeutic considerations by Magkas, Nikolaos, Tsioufis, Costas, Thomopoulos, Costas, Dilaveris, Polychronis, Georgiopoulos, Georgios, Sanidas, Elias, Papademetriou, Vasilios, Tousoulis, Dimitrios

    “…Orthostatic hypotension (OH), that is blood pressure fall when standing from the supine to the erect position, is a common cardiovascular disorder, highly…”
    Get full text
    Journal Article
  5. 5

    Hypertension in Pregnancy: Unanswered Questions by Papademetriou, Vasilios, Stavropoulos, Konstantinos, Patoulias, Dimitrios, Papadopoulos, Christodoulos, Georgios, Kerpiniotis, Toumpourleka, Maria, Sachinidis, Alexandros

    Published in Current pharmaceutical design (01-01-2021)
    “…Hypertension of pregnancy [office blood pressure (BP) levels≥140/90 mmHg] is fairly common and can affect up to 10% of pregnant women worldwide. Hypertension…”
    Get more information
    Journal Article
  6. 6

    Time in Therapeutic Range, as a Determinant of All‐Cause Mortality in Patients With Hypertension by Doumas, Michael, Tsioufis, Costas, Fletcher, Ross, Amdur, Richard, Faselis, Charles, Papademetriou, Vasilios

    Published in Journal of the American Heart Association (01-11-2017)
    “…Background Accumulating evidence indicates that reducing systolic blood pressure (BP) to <140 mm Hg improves health outcomes; however, an optimal level has not…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Exercise Capacity and Mortality in Black and White Men by KOKKINOS, Peter, MYERS, Jonathan, KOKKINOS, John Peter, PITTARAS, Andreas, NARAYAN, Puneet, MANOLIS, Athanasios, KARASIK, Pamela, GREENBERG, Michael, PAPADEMETRIOU, Vasilios, SINGH, Steven

    Published in Circulation (New York, N.Y.) (05-02-2008)
    “…Exercise capacity is inversely related to mortality risk in healthy individuals and those with cardiovascular diseases. This evidence is based largely on white…”
    Get full text
    Journal Article
  9. 9

    Air pollution and arterial hypertension. A new risk factor is in the air by Sanidas, Elias, Papadopoulos, Dimitris P, Grassos, Harris, Velliou, Maria, Tsioufis, Kostas, Barbetseas, John, Papademetriou, Vasilios

    “…Air pollution is one of the greatest environmental threats and has been implicated for several adverse cardiovascular effects including arterial hypertension…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes by Mottl, Amy K, Buse, John B, Ismail-Beigi, Faramarz, Sigal, Ronald J, Pedley, Carolyn F, Papademetriou, Vasilios, Simmons, Debra L, Katz, Lois, Mychaleckyj, Josyf C, Craven, Timothy E

    “…In people with type 2 diabetes, aggressive control of glycemia, BP, and lipids have resulted in conflicting short-term (<5 years) kidney outcomes. We aimed to…”
    Get full text
    Journal Article
  13. 13

    Halting arterial aging in patients with cardiovascular disease: hypolipidemic and antihypertensive therapy by Papademetriou, Vasilios, Katsiki, Niki, Doumas, Michael, Faselis, Charles

    Published in Current pharmaceutical design (01-01-2014)
    “…Aging is associated with arterial stiffening and subsequent acceleration of pulse wave movement. Traditional cardiovascular risk factors such as hypertension…”
    Get more information
    Journal Article
  14. 14

    Exercise Capacity and Progression From Prehypertension to Hypertension by Faselis, Charles, Doumas, Michael, Kokkinos, John Peter, Panagiotakos, Demosthenes, Kheirbek, Raya, Sheriff, Helen M, Hare, Katherine, Papademetriou, Vasilios, Fletcher, Ross, Kokkinos, Peter

    Published in Hypertension (Dallas, Tex. 1979) (01-08-2012)
    “…Prehypertension is likely to progress to hypertension. The rate of progression is determined mostly by age and resting blood pressure but may also be…”
    Get full text
    Journal Article
  15. 15

    Sodium-glucose Cotransporter 2 Inhibitors: The Impact on Development and Progression of Heart Failure by Papademetriou, Vasilios, Geladari, Eleni

    “…Available hypoglycemic-agents enable physicians to achieve consistent glycemic-control, but effects on cardiovascular-outcomes have been marginal or…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events by Papademetriou, Vasilios, MD

    Published in The American heart journal (01-06-2009)
    “…Blood pressure (BP) is a continuous risk factor for ischemic and atherosclerotic events such as stroke and ischemic heart disease, and controlling BP is a…”
    Get full text
    Journal Article
  18. 18

    Comparison of Nebivolol Monotherapy Versus Nebivolol in Combination With Other Antihypertensive Therapies for the Treatment of Hypertension by Papademetriou, Vasilios, MD

    Published in The American journal of cardiology (15-01-2009)
    “…Nebivolol is a novel, β1 -adrenergic receptor blocker with vasodilatory properties mediated through the activation of the l -arginine/nitric oxide pathway…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction by Papademetriou, Vasilios, Toumpourleka, Maria, Imprialos, Konstantinos P, Alataki, Sofia, Manafis, Alexandros, Stavropoulos, Konstantinos

    Published in Current pharmaceutical design (01-01-2018)
    “…Heart failure (HF) is a worldwide modern epidemic, associated with significant morbidity and mortality. Several causes have been identified for the syndrome,…”
    Get more information
    Journal Article